MOPA — Medical Oncology Prior Authorization
0.1.1-snapshot-080926 - snapshot-080926 United States of America flag

MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

ValueSet: Treatment Line Value Set (Experimental)

Official URL: http://hl7.org/fhir/us/codex-mopa/ValueSet/treatment-line-vs Version: 0.1.1-snapshot-080926
Standards status: Informative Computable Name: TreatmentLineVS

Codes representing the ordinal line of systemic anti-cancer therapy. Used by LineOfTherapyRequestCategory for the patient-specific RequestGroup category.

mCODE Migration Candidate — Proposed for mCODE STU5.

References

⚠ mCODE Migration Candidate

This Treatment Line Value Set is defined in this IG as a temporary home while a formal proposal to incorporate it into mCODE STU5 is developed. It is not intended to be a permanent artifact of the MOPA IG. Once adopted by mCODE, this IG will remove its local definition and reference the mCODE canonical URL instead.

This artifact carries status = draft and experimental = true. Canonical URLs will change at migration. See the mCODE Gap Proposals page for the full proposal backlog.

Logical Definition (CLD)

 

Expansion

Expansion performed internally based on codesystem Treatment Line Code System v0.1.1-snapshot-080926 (CodeSystem)

This value set contains 4 concepts

SystemCodeDisplay (en)DefinitionJSONXML
http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs  1LFirst-lineThe first line of systemic anti-cancer therapy for this indication.
http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs  2LSecond-lineThe second line of systemic anti-cancer therapy; administered after first-line therapy failure, progression, or intolerance.
http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs  3L-plusThird-line or laterThe third or any subsequent line of systemic anti-cancer therapy.
http://hl7.org/fhir/us/codex-mopa/CodeSystem/treatment-line-cs  maintenanceMaintenanceMaintenance therapy administered to prolong response after induction or consolidation treatment.

Description of the above table(s).